These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 16990361
1. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy? Vaile L, Finlay F. Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361 [No Abstract] [Full Text] [Related]
2. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreëls FJ. Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191 [Abstract] [Full Text] [Related]
3. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience. Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G. Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402 [Abstract] [Full Text] [Related]
4. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach. Khan WU, Campisi P, Nadarajah S, Shakur YA, Khan N, Semenuk D, McCann C, Roske L, McConney-Ellis S, Joseph M, Parra D, Amaral J, John P, Temple M, Connolly B. Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533 [Abstract] [Full Text] [Related]
5. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy. Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S. Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276 [Abstract] [Full Text] [Related]
6. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option? Nordgarden H, Østerhus I, Møystad A, Asten P, Johnsen UL, Storhaug K, Loven JØ. J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695 [Abstract] [Full Text] [Related]
7. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling. Reid SM, Walstab JE, Chong D, Westbury C, Reddihough DS. J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253 [Abstract] [Full Text] [Related]
8. [Treatment of drooling with botulinum toxin type A in cerebral palsy]. Duarte CS, Alves TR, Azeredo PM, Almeida SI. Rev Neurol; 2013 Jan; 49(11):610. PubMed ID: 19921629 [No Abstract] [Full Text] [Related]
9. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC. J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374 [Abstract] [Full Text] [Related]
10. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review. Porte M, Chaléat-Valayer E, Patte K, D'Anjou MC, Boulay C, Laffont I. Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915 [Abstract] [Full Text] [Related]
12. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Savarese R, Diamond M, Elovic E, Millis SR. Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333 [Abstract] [Full Text] [Related]
13. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ. Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830 [Abstract] [Full Text] [Related]
18. Botulinum toxin A as a treatment for excessive drooling in children. Bothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood EP, Camfield CS, Camfield PR. Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968 [Abstract] [Full Text] [Related]
19. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Wilken B, Aslami B, Backes H. Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707 [Abstract] [Full Text] [Related]